West Breaks Ground for New Molding Facility in China

West Pharmaceutical Services, Inc., a manufacturer of technology for injectable drug administration, rcecently broke ground on a compression molding plant in the Shanghai Qingpu Industrial Zone (SQIZ) in China. The new plant will be adjacent to West’s injection molding facility that opened in 2009.

When completed, the plant will manufacture components used for pharmaceutical packaging, supplying customers primarily in China and the Asia-Pacific region. The 11,900-square-meter facility is expected to begin production in January 2013, officials noted.

“West is experiencing an exciting period of growth in the Asia-Pacific region and we are proud to begin our second manufacturing facility in China,” said Donald E. Morel, Jr., West’s chairman and CEO. “This facility is being established to provide better service to our customers in China, offering shorter lead times for delivery of our world-class pharmaceutical packaging products and creating new, flexible capacity to meet the growing needs of new customers in China and throughout the Asia-Pacific region. Our investment in this new facility demonstrates our commitment to and confidence in the China market.”

In addition to the injection molding plant in Qingpu, West’s presence in the Asia-Pacific region includes a factory in Singapore and sales offices in Australia, China, India and Singapore. West is also an equity partner of Daikyo Seiko, Ltd., Tokyo, Japan. Daikyo Seiko, founded in 1954, is a makes pharmaceutical packaging and medical device components.

West’s sales in 2010 totaled US$1.1 billion. Global headquarters are in Lionville, Pa.

Keep Up With Our Content. Subscribe To Medical Product Outsourcing Newsletters